Search

Your search keyword '"Price, Karen"' showing total 1,342 results

Search Constraints

Start Over You searched for: Author "Price, Karen" Remove constraint Author: "Price, Karen"
1,342 results on '"Price, Karen"'

Search Results

152. Begging tactics of nestling yellow-headed blackbirds, Xanthocephalus xanthocephalus, in relation to need

153. Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia

155. Adherence to daily HIV pre-exposure prophylaxis in a large-scale implementation study in New South Wales, Australia.

160. Effect of systemic adjuvant treatment on first sites of breast cancer relapse

161. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V

162. Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker?

163. Nathan MacKinnon

165. Identifying Breast Cancer Patients at High Risk for Bone Metastases

166. Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

170. Additional file 1: of Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial

172. Author response: Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease

173. Limited Sustained Local Transmission of HIV-1 CRF01_AE in New South Wales, Australia

176. Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

179. Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

180. Present and future projects of the International Breast Cancer Study Group

181. PROPEL: visual arts in Pittsburgh

182. Congress tackles 'energy independence' before taking on climate debate

183. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study

184. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

185. Abstract LB-B33: Nonclinical safety evaluation of two distinct second generation variants of anti-CTLA4 monoclonal antibody, ipilimumab, in monkeys

186. What will the Democratic-controlled 110th congress mean for energy policy?

187. EPAct 2005 boosts incentives for renewables: EPAct 2005 creates a new category of tax credit bonds that can be issued by governmental bodies (defined as state and municipal electric utilities and Indian Tribes) and rural electric cooperatives to finance the construction of renewable energy facilities

188. 109th Congress: what can NWPPA members expect? Of direct interest to the Northwest Public Power Association (NWPPA), the Northwest Congressional delegation will be losing two of its senior members, Washington Republican House Members Jennifer Dunn and George Nethercutt

189. Congress goes home to campaign with much unfinished business

190. Predictive Value of Tumor Ki-67 Expression in Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

191. CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

193. Energy bill stalled as congress leaves to campaign

195. The power of public power: its people. (Washington D.C. Report)

197. Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

198. Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

199. Chemotherapy (CT) for isolated locoregional recurrence (ILRR) of breast cancer in ER-positive (ER+) and ER-negative (ER-) cohorts: Final analysis of the CALOR trial.

Catalog

Books, media, physical & digital resources